CN104293875B - The method that biological enzyme prepares (S) 2 chlorobenzene glycine methyl ester single enantiomer - Google Patents
The method that biological enzyme prepares (S) 2 chlorobenzene glycine methyl ester single enantiomer Download PDFInfo
- Publication number
- CN104293875B CN104293875B CN201410532820.5A CN201410532820A CN104293875B CN 104293875 B CN104293875 B CN 104293875B CN 201410532820 A CN201410532820 A CN 201410532820A CN 104293875 B CN104293875 B CN 104293875B
- Authority
- CN
- China
- Prior art keywords
- methyl ester
- acylase
- chlorophenylglycine
- penicillin
- racemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种利用生物酶催化制备(S)‑2‑氯苯甘氨酸甲酯单一对映体的方法,包括以下步骤:在水浴恒温30℃的反应器中加入外消旋2‑氯苯甘氨酸甲酯和磷酸钠缓冲溶液,搅拌后加入青霉素G酰化酶,控制搅拌转速为100‑500r/min,控制反应时间20‑60小时,持续搅拌直至反应结束,最后回收青霉素G酰化酶。本发明的有益之处在于:采用PGA作催化剂,利用其活性、高选择性和对底物的专一性,在常温、常压下进行反应,一步制备(S)‑2‑氯苯甘氨酸甲酯,既省去了氯苯甘氨酸中反应性基团的保护与去保护过程,又获得了光学纯度更高的(S)‑2‑氯苯甘氨酸甲酯单一对映体,对映体对量值达95%以上;本发明的方法操作过程简捷易控制,制备过程能耗低,排放少,是环境友好绿色化制备方法。The invention discloses a method for preparing a single enantiomer of (S)-2-chlorophenylglycine methyl ester catalyzed by biological enzymes, comprising the following steps: adding racemic 2-chlorobenzene to a reactor with a constant temperature of 30°C in a water bath Glycine methyl ester and sodium phosphate buffer solution, after stirring, add penicillin G acylase, control the stirring speed to 100-500r/min, control the reaction time for 20-60 hours, keep stirring until the end of the reaction, and finally recover penicillin G acylase. The present invention is beneficial in that: using PGA as a catalyst, utilizing its activity, high selectivity and specificity to the substrate, reacting at normal temperature and normal pressure, one-step preparation of (S)-2-chlorophenylglycine methyl ester, which not only saves the protection and deprotection process of the reactive group in chlorophenylglycine, but also obtains a single enantiomer of (S)‑2‑chlorophenylglycine methyl ester with higher optical purity, and the enantiomeric ratio The value reaches more than 95%; the method of the invention is simple and easy to control, has low energy consumption and less emission in the preparation process, and is an environmentally friendly and green preparation method.
Description
技术领域technical field
本发明涉及制备(S)-2-氯苯甘氨酸甲酯单一对映体的方法,具体涉及利用生物酶催化制备(S)-2-氯苯甘氨酸甲酯单一对映体的方法,属于医药技术领域。The invention relates to a method for preparing a single enantiomer of (S)-2-chlorophenylglycine methyl ester, in particular to a method for preparing a single enantiomer of (S)-2-chlorophenylglycine methyl ester catalyzed by biological enzymes, which belongs to medical technology field.
背景技术Background technique
2-氯苯甘氨酸是具有生物活性的非天然氨基酸,(S)-2-氯苯甘氨酸甲酯是治疗血栓性疾病新药氯吡格雷的关键手性结构单元。氯吡格雷是一种安全、有效的血小板聚集抑制剂,具有药效显著、安全和耐受性强等特性,目前已大量用于临床治疗。2-Chlorophenylglycine is a biologically active unnatural amino acid, and (S)-2-chlorophenylglycine methyl ester is the key chiral structural unit of the new drug clopidogrel for the treatment of thrombotic diseases. Clopidogrel is a safe and effective platelet aggregation inhibitor with remarkable efficacy, safety and strong tolerance, and has been widely used in clinical treatment.
氯吡格雷是手性药,其S-构型的分子具有强的血小板凝聚抑制活性,耐受性是R-构型的40倍,且R-构型用药后会产生抽搐副作用,因此氯吡格雷是以S-构型作为药物进行销售。用(S)-2-氯苯甘氨酸甲酯单一对映体直接合成(S)-氯吡格雷,既省去了手性试剂后拆分过程,又提高了原料的利用率和产品的质量,是生产氯吡格雷手性药最理想的途径。化学法制备(S)-2-氯苯甘氨酸甲酯通常用D-樟脑磺酸和L-酒石酸等手性试剂进行拆分(US6812363B2,2002-10-15),但该方法所需要的手性拆分剂昂贵,产品纯度较低,操作过程繁杂,生产效率低下。Clopidogrel is a chiral drug, and its S-configuration molecule has strong platelet aggregation inhibitory activity, and its tolerance is 40 times that of the R-configuration, and the R-configuration will produce convulsions after administration, so clopidogrel Gray is marketed as a drug in the S-configuration. The direct synthesis of (S)-clopidogrel with the single enantiomer of (S)-2-chlorophenylglycine methyl ester not only saves the resolution process after the chiral reagent, but also improves the utilization rate of raw materials and the quality of the product. It is the most ideal way to produce clopidogrel chiral drug. The preparation of (S)-2-chlorophenylglycine methyl ester by chemical method is usually resolved with chiral reagents such as D-camphorsulfonic acid and L-tartaric acid (US6812363B2, 2002-10-15), but the required chiral The resolving agent is expensive, the product purity is low, the operation process is complicated, and the production efficiency is low.
因此,工业化生产迫切需要开发一种高效、低成本的(S)-2-氯苯甘氨酸甲酯单一对映体的制备技术。Therefore, industrial production urgently needs to develop a high-efficiency, low-cost (S)-2-chlorophenylglycine methyl ester single enantiomer preparation technology.
发明内容Contents of the invention
为解决现有技术的不足,本发明的目的在于提供一种高效、低成本的、利用生物酶催化制备(S)-2-氯苯甘氨酸甲酯单一对映体的方法。In order to solve the deficiencies of the prior art, the object of the present invention is to provide a method for preparing (S)-2-chlorophenylglycine methyl ester single enantiomer with high efficiency and low cost by utilizing biological enzyme catalysis.
为了实现上述目标,本发明采用如下的技术方案:In order to achieve the above object, the present invention adopts the following technical solutions:
生物酶催化制备(S)-2-氯苯甘氨酸甲酯单一对映体的方法,其特征在于,包括以下步骤:The method for preparing the single enantiomer of (S)-2-chlorophenylglycine methyl ester catalyzed by biological enzymes is characterized in that it comprises the following steps:
(1)在水浴恒温30℃的反应器中加入外消旋2-氯苯甘氨酸甲酯和磷酸钠缓冲溶液,前述外消旋2-氯苯甘氨酸甲酯的浓度为20-200g/L,前述磷酸钠缓冲溶液的pH值为6.0-9.0,浓度为0.01-0.50mol/L;(1) Add racemic 2-chlorophenylglycine methyl ester and sodium phosphate buffer solution in a reactor with a constant temperature of 30°C in a water bath, the concentration of the aforementioned racemic 2-chlorophenylglycine methyl ester is 20-200g/L, the aforementioned The pH value of the sodium phosphate buffer solution is 6.0-9.0, and the concentration is 0.01-0.50mol/L;
(2)搅拌后加入青霉素G酰化酶,青霉素G酰化酶与外消旋2-氯苯甘氨酸甲酯的质量比为1:1~100;(2) After stirring, add penicillin G acylase, the mass ratio of penicillin G acylase to racemic 2-chlorophenylglycine methyl ester is 1:1-100;
(3)继续搅拌使青霉素G酰化酶与外消旋2-氯苯甘氨酸甲酯充分接触,控制搅拌转速为100-500r/min,控制反应时间20-60小时,持续搅拌直至反应结束;(3) Continue stirring to make the penicillin G acylase fully contact with racemic 2-chlorophenylglycine methyl ester, control the stirring speed to be 100-500r/min, control the reaction time for 20-60 hours, and continue stirring until the reaction ends;
(4)反应结束后,回收青霉素G酰化酶。(4) After the reaction is finished, the penicillin G acylase is recovered.
前述的制备方法,其特征在于,前述外消旋2-氯苯甘氨酸甲酯的浓度为50-150g/L。The aforementioned preparation method is characterized in that the concentration of the aforementioned racemic 2-chlorophenylglycine methyl ester is 50-150 g/L.
前述的制备方法,其特征在于,前述磷酸钠缓冲溶液的pH值为7.0-8.0,浓度为0.05-0.20mol/L。The aforementioned preparation method is characterized in that the pH value of the aforementioned sodium phosphate buffer solution is 7.0-8.0, and the concentration is 0.05-0.20 mol/L.
前述的制备方法,其特征在于,前述青霉素G酰化酶为商品固定化青霉素G酰化酶IPA750或Eupergit C。The aforementioned preparation method is characterized in that the aforementioned penicillin G acylase is commercial immobilized penicillin G acylase IPA750 or Eupergit C.
前述的制备方法,其特征在于,前述青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为1:10~50。The aforementioned preparation method is characterized in that the mass ratio of the aforementioned penicillin G acylase to 2-chlorophenylglycine methyl ester is 1:10-50.
前述的制备方法,其特征在于,控制搅拌转速为200-400r/min。The aforementioned preparation method is characterized in that the stirring speed is controlled to be 200-400r/min.
本发明的有益之处在于:The benefits of the present invention are:
1、本发明采用青霉素G酰化酶(Penicillin G acylase,EC 3.5.1.11,简称PGA)作催化剂,利用PGA的高活性、高选择性和对底物的专一性,在常温、常压下进行反应,一步制备(S)-2-氯苯甘氨酸甲酯,既省去了氯苯甘氨酸中反应性基团的保护与去保护过程,又获得了光学纯度更高的(S)-2-氯苯甘氨酸甲酯单一对映体,对映体对量值达95%以上;1. The present invention adopts penicillin G acylase (Penicillin G acylase, EC 3.5.1.11, referred to as PGA) as a catalyst, utilizes the high activity, high selectivity and specificity to substrate of PGA, under normal temperature and normal pressure Carrying out the reaction to prepare (S)-2-chlorophenylglycine methyl ester in one step, which not only saves the protection and deprotection process of reactive groups in chlorophenylglycine, but also obtains (S)-2- Chlorphenylglycine methyl ester is a single enantiomer, and the enantiomer pair value is over 95%;
2、目前青霉素G酰化酶已能高效表达和大批量的生产,成本低,其催化外消旋2-氯苯甘氨酸甲酯发生不对称水解反应,操作过程简捷易控制,制备过程能耗低,排放少,是环境友好绿色化制备方法。2. At present, penicillin G acylase has been able to be efficiently expressed and mass-produced with low cost. It catalyzes the asymmetric hydrolysis reaction of racemic 2-chlorophenylglycine methyl ester. The operation process is simple and easy to control, and the energy consumption of the preparation process is low. , less emission, and is an environmentally friendly and green preparation method.
具体实施方式detailed description
本发明生物酶催化制备(S)-2-氯苯甘氨酸甲酯单一对映体的方法,其关键在于:青霉素G酰化酶催化外消旋2-氯苯甘氨酸甲酯发生不对称水解,即:The method for the preparation of (S)-2-chlorophenylglycine methyl ester single enantiomer catalyzed by the biological enzyme of the present invention, its key lies in: the asymmetric hydrolysis of racemic 2-chlorophenylglycine methyl ester catalyzed by penicillin G acylase, namely :
利用PGA的高活性、高选择性和对底物的专一性,在常温、常压下进行水解反应,一步制备(S)-2-氯苯甘氨酸甲酯,既省去了氯苯甘氨酸中反应性基团的保护与去保护过程,又获得了光学纯度更高的(S)-2-氯苯甘氨酸甲酯单一对映体。Utilizing the high activity, high selectivity and specificity of PGA to the substrate, the hydrolysis reaction is carried out at normal temperature and normal pressure to prepare (S)-2-chlorophenylglycine methyl ester in one step, which saves the chlorophenylglycine. During the protection and deprotection process of the reactive group, a single enantiomer of (S)-2-chlorophenylglycine methyl ester with higher optical purity was obtained.
以下结合具体实施例对本发明作具体的介绍。The present invention will be specifically introduced below in conjunction with specific embodiments.
实施例1Example 1
在反应器中加入5.0g外消旋2-氯苯甘氨酸甲酯和50mL pH 7.0、0.2mol/L磷酸钠缓冲溶液,此时外消旋2-氯苯甘氨酸甲酯的浓度为100g/L,然后加入0.1g固定化青霉素G酰化酶IPA750,此时固定化青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为1:50,水浴控温恒温于30℃,控制转速为300r/min,反应30小时,最后分离出固定化酶。In reactor, add 5.0g racemic 2-chlorophenylglycine methyl ester and 50mL pH 7.0, 0.2mol/L sodium phosphate buffer solution, now the concentration of racemic 2-chlorophenylglycine methyl ester is 100g/L, Then add 0.1 g of immobilized penicillin G acylase IPA750. At this time, the mass ratio of immobilized penicillin G acylase to 2-chlorophenylglycine methyl ester is 1:50. The temperature of the water bath is controlled at 30°C and the speed is controlled at 300r. /min, reacted for 30 hours, and finally separated the immobilized enzyme.
反应器可以采用工业上常用的间歇式反应器。The reactor can adopt the batch reactor commonly used in industry.
实施例2Example 2
在反应器中加入5.0g外消旋2-氯苯甘氨酸甲酯和50mL pH 7.0、0.2mol/L磷酸钠缓冲溶液,此时外消旋2-氯苯甘氨酸甲酯的浓度为100g/L,然后加入0.2g固定化青霉素G酰化酶IPA750,此时固定化青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为2:50,水浴控温恒温于30℃,控制转速为300r/min,反应20小时,最后分离出固定化酶。In reactor, add 5.0g racemic 2-chlorophenylglycine methyl ester and 50mL pH 7.0, 0.2mol/L sodium phosphate buffer solution, now the concentration of racemic 2-chlorophenylglycine methyl ester is 100g/L, Then add 0.2 g of immobilized penicillin G acylase IPA750, at this time the mass ratio of immobilized penicillin G acylase to 2-chlorophenylglycine methyl ester is 2:50, the temperature of the water bath is controlled at 30°C, and the control speed is 300r /min, reacted for 20 hours, and finally separated the immobilized enzyme.
实施例3Example 3
在反应器中加入5.0g外消旋2-氯苯甘氨酸甲酯和50mL pH 7.0、0.01mol/L磷酸钠缓冲溶液,此时外消旋2-氯苯甘氨酸甲酯的浓度为100g/L,然后加入0.1g固定化青霉素G酰化酶IPA750,此时固定化青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为1:50,水浴控温恒温于30℃,控制转速为300r/min,反应30小时,最后分离出固定化酶。Add 5.0g racemic 2-chlorophenylglycine methyl ester and 50mL pH 7.0, 0.01mol/L sodium phosphate buffer solution in reactor, the concentration of racemic 2-chlorophenylglycine methyl ester is 100g/L now, Then add 0.1 g of immobilized penicillin G acylase IPA750. At this time, the mass ratio of immobilized penicillin G acylase to 2-chlorophenylglycine methyl ester is 1:50. The temperature of the water bath is controlled at 30°C and the speed is controlled at 300r. /min, reacted for 30 hours, and finally separated the immobilized enzyme.
实施例4Example 4
在反应器中加入5.0g外消旋2-氯苯甘氨酸甲酯和50mL pH 8.0、0.05mol/L磷酸钠缓冲溶液,此时外消旋2-氯苯甘氨酸甲酯的浓度为100g/L,然后加入0.1g固定化青霉素G酰化酶IPA750,此时固定化青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为1:50,水浴控温恒温于30℃,控制转速为300r/min,反应30小时,最后分离出固定化酶。In reactor, add 5.0g racemic 2-chlorophenylglycine methyl ester and 50mL pH 8.0, 0.05mol/L sodium phosphate buffer solution, now the concentration of racemic 2-chlorophenylglycine methyl ester is 100g/L, Then add 0.1 g of immobilized penicillin G acylase IPA750. At this time, the mass ratio of immobilized penicillin G acylase to 2-chlorophenylglycine methyl ester is 1:50. The temperature of the water bath is controlled at 30°C and the speed is controlled at 300r. /min, reacted for 30 hours, and finally separated the immobilized enzyme.
实施例5Example 5
在反应器中加入2.5g外消旋2-氯苯甘氨酸甲酯和50mL pH 7.0、0.2mol/L磷酸钠缓冲溶液,此时外消旋2-氯苯甘氨酸甲酯的浓度为50g/L,然后加入0.1g固定化青霉素G酰化酶Eupergit C,此时固定化青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为1:25,水浴控温恒温于30℃,控制转速为200r/min,反应30小时,最后分离出固定化酶。In reactor, add 2.5g racemic 2-chlorophenylglycine methyl ester and 50mL pH 7.0, 0.2mol/L sodium phosphate buffer solution, now the concentration of racemic 2-chlorophenylglycine methyl ester is 50g/L, Then add 0.1 g of immobilized penicillin G acylase Eupergit C. At this time, the mass ratio of immobilized penicillin G acylase to 2-chlorophenylglycine methyl ester is 1:25. 200r/min, react for 30 hours, and finally separate the immobilized enzyme.
实施例6Example 6
在反应器中加入2.5g外消旋2-氯苯甘氨酸甲酯和50mL pH 7.0、0.1mol/L磷酸钠缓冲溶液,此时外消旋2-氯苯甘氨酸甲酯的浓度为50g/L,然后加入0.1g固定化青霉素G酰化酶Eupergit C,此时固定化青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为1:25,水浴控温恒温于30℃,控制转速为300r/min,反应30小时,最后分离出固定化酶。In reactor, add 2.5g racemic 2-chlorophenylglycine methyl ester and 50mL pH 7.0, 0.1mol/L sodium phosphate buffer solution, now the concentration of racemic 2-chlorophenylglycine methyl ester is 50g/L, Then add 0.1 g of immobilized penicillin G acylase Eupergit C. At this time, the mass ratio of immobilized penicillin G acylase to 2-chlorophenylglycine methyl ester is 1:25. 300r/min, react for 30 hours, and finally separate the immobilized enzyme.
实施例7Example 7
在反应器中加入5.0g外消旋2-氯苯甘氨酸甲酯和50mL pH 7.0、0.1mol/L磷酸钠缓冲溶液,此时外消旋2-氯苯甘氨酸甲酯的浓度为100g/L,然后加入0.1g固定化青霉素G酰化酶Eupergit C,此时固定化青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为1:50,水浴控温恒温于30℃,控制转速为400r/min,反应40小时,最后分离出固定化酶。Add 5.0g racemic 2-chlorophenylglycine methyl ester and 50mL pH 7.0, 0.1mol/L sodium phosphate buffer solution in reactor, the concentration of racemic 2-chlorophenylglycine methyl ester is 100g/L now, Then add 0.1 g of immobilized penicillin G acylase Eupergit C. At this time, the mass ratio of immobilized penicillin G acylase to 2-chlorophenylglycine methyl ester is 1:50. 400r/min, react for 40 hours, and finally separate the immobilized enzyme.
实施例8Example 8
在反应器中加入1.0g外消旋2-氯苯甘氨酸甲酯和50mL pH 8.0、0.01mol/L磷酸钠缓冲溶液,此时外消旋2-氯苯甘氨酸甲酯的浓度为20g/L,然后加入0.01g固定化青霉素G酰化酶IPA750,此时固定化青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为1:100,水浴控温恒温于30℃,控制转速为300r/min,反应30小时,最后分离出固定化酶。Add 1.0g racemic 2-chlorophenylglycine methyl ester and 50mL pH 8.0, 0.01mol/L sodium phosphate buffer solution in reactor, the concentration of racemic 2-chlorophenylglycine methyl ester is 20g/L now, Then add 0.01g of immobilized penicillin G acylase IPA750. At this time, the mass ratio of immobilized penicillin G acylase to 2-chlorophenylglycine methyl ester is 1:100. The temperature of the water bath is controlled at 30°C, and the control speed is 300r. /min, reacted for 30 hours, and finally separated the immobilized enzyme.
实施例9Example 9
在反应器中加入10.0g外消旋2-氯苯甘氨酸甲酯和50mL pH 8.0、0.05mol/L磷酸钠缓冲溶液,此时外消旋2-氯苯甘氨酸甲酯的浓度为200g/L,然后加入10.0g固定化青霉素G酰化酶Eupergit C,此时固定化青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为1:1,水浴控温恒温于30℃,控制转速为300r/min,反应60小时,最后分离出固定化酶。In reactor, add 10.0g racemic 2-chlorophenylglycine methyl ester and 50mL pH 8.0, 0.05mol/L sodium phosphate buffer solution, now the concentration of racemic 2-chlorophenylglycine methyl ester is 200g/L, Then add 10.0 g of immobilized penicillin G acylase Eupergit C. At this time, the mass ratio of immobilized penicillin G acylase to 2-chlorophenylglycine methyl ester is 1:1. 300r/min, react for 60 hours, and finally separate the immobilized enzyme.
实施例10Example 10
在反应器中加入7.5g外消旋2-氯苯甘氨酸甲酯和50mL pH 8.0、0.01mol/L磷酸钠缓冲溶液,此时外消旋2-氯苯甘氨酸甲酯的浓度为150g/L,然后加入0.75g固定化青霉素G酰化酶IPA750,此时固定化青霉素G酰化酶与2-氯苯甘氨酸甲酯的质量比为1:10,水浴控温恒温于30℃,控制转速为300r/min,反应50小时,最后分离出固定化酶。Add 7.5g racemic 2-chlorophenylglycine methyl ester and 50mL pH 8.0, 0.01mol/L sodium phosphate buffer solution in reactor, the concentration of racemic 2-chlorophenylglycine methyl ester is 150g/L now, Then add 0.75g of immobilized penicillin G acylase IPA750. At this time, the mass ratio of immobilized penicillin G acylase to 2-chlorophenylglycine methyl ester is 1:10. The temperature of the water bath is controlled at 30°C, and the control speed is 300r. /min, reacted for 50 hours, and finally separated the immobilized enzyme.
需要说明的是,在本发明的制备方法中:It should be noted that, in the preparation method of the present invention:
(1)磷酸钠缓冲溶液的pH值可以在6.0-9.0范围内调整,优选的pH值为7.0-8.0,磷酸钠缓冲溶液的浓度可以在0.01-0.50mol/L范围内调整,优选的浓度为0.05-0.20mol/L,在上述范围内青霉素G酰化酶均具有较高的催化活性;(1) The pH value of sodium phosphate buffer solution can be adjusted in the scope of 6.0-9.0, and preferred pH value is 7.0-8.0, and the concentration of sodium phosphate buffer solution can be adjusted in the scope of 0.01-0.50mol/L, and preferred concentration is 0.05-0.20mol/L, penicillin G acylase has higher catalytic activity within the above range;
(2)根据实际生产过程的需要,搅拌转速可以在100-500r/min范围内调整。(2) According to the needs of the actual production process, the stirring speed can be adjusted within the range of 100-500r/min.
反应液中(S)-2-氯苯甘氨酸甲酯和(R)-2-氯苯甘氨酸由装有进口手性柱的高效液相色谱仪进行定量分析,(S)-2-氯苯甘氨酸甲酯和(R)-2-氯苯甘氨酸的对映体过量值分别用ees(%)和eep(%)表示,反应总转化率用C(%)表示,其计算如下:(S)-2-chlorophenylglycine methyl ester and (R)-2-chlorophenylglycine in the reaction solution are quantitatively analyzed by high-performance liquid chromatography equipped with imported chiral columns, and (S)-2-chlorophenylglycine The enantiomeric excess values of methyl ester and (R)-2-chlorophenylglycine are represented by ee s (%) and ee p (%) respectively, and the total conversion rate of the reaction is represented by C (%), which is calculated as follows:
ees=(cSS–cRS)/(cSS+cRS)ee s = (c SS –c RS )/(c SS +c RS )
eep=(cRP–cSP)/(cRP+cSP)ee p = (c RP -c SP )/(c RP +c SP )
C(%)=ees/(ees+eep)C(%)=ee s /(ee s +ee p )
式中,cSS为(S)-2-氯苯甘氨酸甲酯的浓度,mol/L;In the formula, c SS is the concentration of (S)-2-chlorophenylglycine methyl ester, mol/L;
cRS为(R)-2-氯苯甘氨酸甲酯的浓度,mol/L;c RS is the concentration of (R)-2-chlorophenylglycine methyl ester, mol/L;
cRP为(R)-2-氯苯甘氨酸的浓度,mol/L;c RP is the concentration of (R)-2-chlorophenylglycine, mol/L;
cSP为(S)-2-氯苯甘氨酸的浓度,mol/L。c SP is the concentration of (S)-2-chlorophenylglycine, mol/L.
采用现有的方法制备而来的(S)-2-氯苯甘氨酸甲酯单一对映体,其光学纯度一般可以达到70-90%。The single enantiomer of (S)-2-chlorophenylglycine methyl ester prepared by the existing method generally has an optical purity of 70-90%.
采用本发明的方法制备而来的(S)-2-氯苯甘氨酸甲酯单一对映体,其光学纯度见表1。The optical purity of the single enantiomer of (S)-2-chlorophenylglycine methyl ester prepared by the method of the present invention is shown in Table 1.
表1(S)-2-氯苯甘氨酸甲酯单一对映体的光学纯度Table 1 (S) - Optical purity of the single enantiomer of 2-chlorophenylglycine methyl ester
由此可见,本发明用青霉素G酰化酶催化外消旋2-氯苯甘氨酸甲酯制备(S)-2-氯苯甘氨酸甲酯,突出的优势是获得的(S)-2-氯苯甘氨酸甲酯单一对映体纯度更高,ees可以达到95%以上。It can be seen that the present invention uses penicillin G acylase to catalyze racemic 2-chlorophenylglycine methyl ester to prepare (S)-2-chlorophenylglycine methyl ester, and the outstanding advantage is that the (S)-2-chlorophenylglycine methyl ester obtained is The single enantiomer of glycine methyl ester has a higher purity, and the ee s can reach more than 95%.
另外,由前面的各实施例还可以看出,本发明的方法具有制备过程简捷、反应条件温和、成本低等特点,非常适合工业化生产。In addition, it can also be seen from the above examples that the method of the present invention has the characteristics of simple and convenient preparation process, mild reaction conditions and low cost, and is very suitable for industrial production.
需要说明的是,上述实施例不以任何形式限制本发明,凡采用等同替换或等效变换的方式所获得的技术方案,均落在本发明的保护范围内。It should be noted that the above embodiments do not limit the present invention in any form, and all technical solutions obtained by means of equivalent replacement or equivalent transformation fall within the protection scope of the present invention.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410532820.5A CN104293875B (en) | 2014-10-11 | 2014-10-11 | The method that biological enzyme prepares (S) 2 chlorobenzene glycine methyl ester single enantiomer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410532820.5A CN104293875B (en) | 2014-10-11 | 2014-10-11 | The method that biological enzyme prepares (S) 2 chlorobenzene glycine methyl ester single enantiomer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104293875A CN104293875A (en) | 2015-01-21 |
CN104293875B true CN104293875B (en) | 2017-07-07 |
Family
ID=52313823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410532820.5A Expired - Fee Related CN104293875B (en) | 2014-10-11 | 2014-10-11 | The method that biological enzyme prepares (S) 2 chlorobenzene glycine methyl ester single enantiomer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104293875B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111117983B (en) * | 2020-01-14 | 2021-10-01 | 浙江工业大学 | A lipase mutant and its application in the preparation of (S)-2-chlorophenylglycine methyl ester |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101253271A (en) * | 2005-09-02 | 2008-08-27 | 第一精密化学株式会社 | Method for production of optically active alpha-hydroxycarboxylic acid |
CN102056931A (en) * | 2008-06-09 | 2011-05-11 | 安资科技株式会社 | Method for preparing clopidogrel and its derivatives |
-
2014
- 2014-10-11 CN CN201410532820.5A patent/CN104293875B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101253271A (en) * | 2005-09-02 | 2008-08-27 | 第一精密化学株式会社 | Method for production of optically active alpha-hydroxycarboxylic acid |
CN102056931A (en) * | 2008-06-09 | 2011-05-11 | 安资科技株式会社 | Method for preparing clopidogrel and its derivatives |
Non-Patent Citations (2)
Title |
---|
D-Phenylglycine and D-4-hydroxyphenylglycine methyl esters via penicillin G acylase catalysed resolution in organic solvents;Alessandra Basso等;《Tetrahedron: Asymmetry》;20000531;第11卷(第8期);1789-1796 * |
Resolution of racemic 2-chlorophenyl glycine with immobilized penicillin G acylase;Fadnavis NW等;《Tetrahedron:Asymmetry》;20081020;第19卷(第20期);2363-2366 * |
Also Published As
Publication number | Publication date |
---|---|
CN104293875A (en) | 2015-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107058416B (en) | Fermentation process for refining glutamic acid | |
CN107217048A (en) | It is a kind of to catalyze and synthesize aminopeptidase of carnosine and its preparation method and application | |
CN109735559B (en) | A kind of biological preparation method of gamma-aminobutyric acid | |
CN103602710A (en) | Method of preparing calcium gluconate by composite immobilized enzyme | |
CN105861529A (en) | Arginine decarboxylase and application thereof | |
CN103320480A (en) | Method for preparing beta-alanine by coupled enzymatic reaction | |
CN104293875B (en) | The method that biological enzyme prepares (S) 2 chlorobenzene glycine methyl ester single enantiomer | |
WO2020192560A1 (en) | Chiral isoquinoline carboxylic acid and preparation method thereof | |
CN102925418B (en) | Method for recovering sucrose phosphorylase in alpha-arbutin production process | |
CN109777845A (en) | A kind of preparation method of C4H9NO2 | |
CN102258765A (en) | Preparation method of colistin sulfate premix | |
CN104531820A (en) | Method for preparing DL-alanine with fumaric acid as raw material through multi-enzyme coupling | |
CN107916282B (en) | Method for preparing L-citrulline and L-ornithine by biological method | |
CN104745660A (en) | Method for preparing trehalose through enzymatic synthesis | |
CN103981229B (en) | A kind of method of pair of enzymatic synthesis S-Leucine | |
CN102925530A (en) | L-methionine preparation method | |
CN114058655A (en) | A kind of method of enzyme-chemical one-pot synthesis of (R)-acetamidophenylpropanol | |
CN102226208B (en) | Preparation method of D-asparagine | |
CN101863801A (en) | A preparation method of optically active citrulline or homocitrulline | |
KR20080085377A (en) | Method for preparing L-ornithine salt | |
CN102212566A (en) | Method for producing high-purity isobutyramide | |
CN104293851A (en) | Method for producing hydroxyethyl pyridine by alternaria alternata | |
CN104263776B (en) | A kind of living things catalysis produces the method for chiral pyridyl ethanol | |
CN114164238B (en) | Enzymatic synthesis method of L-tyrosine | |
CN114225929B (en) | Catalyst, application and preparation method of trans-tranexamic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170707 Termination date: 20191011 |
|
CF01 | Termination of patent right due to non-payment of annual fee |